Signify Health, Inc. (NYSE:SGFY – Get Rating) has been assigned an average recommendation of “Buy” from the ten research firms that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $26.67.
Several equities analysts have recently issued reports on SGFY shares. Guggenheim started coverage on shares of Signify Health in a report on Tuesday, March 29th. They set a “buy” rating and a $36.00 target price for the company. Zacks Investment Research downgraded shares of Signify Health from a “buy” rating to a “hold” rating in a research report on Friday, January 28th. UBS Group raised shares of Signify Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $20.00 to $21.00 in a research report on Wednesday, March 9th. The Goldman Sachs Group raised their price target on shares of Signify Health from $20.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, March 21st. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Signify Health from $29.00 to $26.00 in a research report on Friday.
In related news, insider Steve Senneff bought 10,000 shares of the business’s stock in a transaction on Friday, May 6th. The stock was acquired at an average price of $12.55 per share, with a total value of $125,500.00. Following the transaction, the insider now owns 215,087 shares in the company, valued at approximately $2,699,341.85. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 8.02% of the company’s stock.
SGFY stock opened at $12.42 on Friday. The firm has a 50 day moving average price of $16.11 and a 200-day moving average price of $14.79. Signify Health has a 52-week low of $11.11 and a 52-week high of $31.91. The firm has a market capitalization of $2.13 billion, a price-to-earnings ratio of 65.37 and a beta of 1.56. The company has a debt-to-equity ratio of 0.22, a quick ratio of 5.46 and a current ratio of 5.46.
Signify Health (NYSE:SGFY – Get Rating) last released its earnings results on Wednesday, May 4th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.09). Signify Health had a net margin of 2.55% and a return on equity of 4.36%. The business had revenue of $216.50 million for the quarter, compared to analysts’ expectations of $213.21 million. During the same quarter in the previous year, the business posted $0.20 earnings per share. Signify Health’s revenue for the quarter was up 20.3% on a year-over-year basis. As a group, sell-side analysts forecast that Signify Health will post 0.27 earnings per share for the current fiscal year.
About Signify Health (Get Rating)
Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.
- Get a free copy of the StockNews.com research report on Signify Health (SGFY)
- Three Stocks To Ride Out A Rough Market
- MarketBeat: Week in Review 5/2 – 5/6
- AMD (NASDAQ: AMD) Shines Green In A Sea Of Red
- Expedia or Bookings Holdings: Which Stock Should You Travel With?
- Is This The Bottom For Papa John’s International?
Receive News & Ratings for Signify Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Signify Health and related companies with MarketBeat.com's FREE daily email newsletter.